Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease

Show other versions (1)

Background and aims: The advent of direct-acting antiviral agents promises to change the management of hepatitis C virus infection (HCV) in patients with chronic kidney disease (CKD), a patient group in which the treatment of hepatitis C was historically challenging. We investigated the safety and e...

Full description

Bibliographic Details
Main Authors: Ezequiel Ridruejo, Rebeca Garcia-Agudo, Manuel Mendizabal, Sami Aoufi-Rabih, Vivek Dixit, Marcelo Silva, Fabrizio Fabrizi
Format: Article
Language:Spanish
Published: Elsevier 2020-01-01
Series:Nefrología
Online Access:http://www.sciencedirect.com/science/article/pii/S0211699519300967

Internet

http://www.sciencedirect.com/science/article/pii/S0211699519300967

Similar Items